Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 06-1995 | 06-1994 | 06-1993 | 06-1992 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -291,000 | -139,152 | 8,000 | -94,000 | -163,000 |
| Other Working Capital | -46,000 | -60,031 | 50,000 | 4,000 | -73,000 |
| Other Operating Activity | 1,589,000 | 2,648,211 | 995,000 | 1,017,000 | 893,000 |
| Operating Cash Flow | $1,252,000 | $2,449,029 | $1,053,000 | $927,000 | $657,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -623,000 | -405,461 | -553,000 | -524,000 | -584,000 |
| Net Acquisitions | -6,845,000 | N/A | -2,000 | -3,000 | N/A |
| Purchase Of Investment | -3,000 | N/A | -4,000 | -25,000 | -6,000 |
| Sale Of Investment | 37,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 2,641,000 | -4,338,437 | -804,000 | -306,000 | 218,000 |
| Investing Cash Flow | $-4,793,000 | $-4,743,898 | $-1,363,000 | $-858,000 | $-372,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,840,000 | N/A | 1,638,000 | 1,902,000 | 1,071,000 |
| Debt Repayment | -7,290,000 | N/A | -1,650,000 | -1,875,000 | -1,561,000 |
| Common Stock Issued | 106,000 | 44,081 | 51,000 | 69,000 | 24,000 |
| Dividend Paid | N/A | -844,077 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 2,984,724 | 0 | 0 | 0 |
| Financing Cash Flow | $3,656,000 | $2,184,729 | $39,000 | $96,000 | $-466,000 |
| Exchange Rate Effect | 4,000 | -3,014 | 18,000 | -32,000 | 72,000 |
| Beginning Cash Position | -2,890,000 | 188,256 | 441,000 | 308,000 | 417,000 |
| End Cash Position | -2,771,000 | 0 | 188,000 | 441,000 | 308,000 |
| Net Cash Flow | $115,000 | $-110,141 | $-271,000 | $165,000 | $-181,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,252,000 | 2,449,029 | 1,053,000 | 927,000 | 657,000 |
| Capital Expenditure | -684,000 | -485,586 | -575,000 | -608,000 | -594,000 |
| Free Cash Flow | 568,000 | 1,963,443 | 478,000 | 319,000 | 63,000 |